คุณอาจชื่นชอบ
Oculis $OCS I am not sure what Roche and Novartis are waiting for. Company has three successful small Phase 2 trials which are de risked to work in larger Phase3s. In two multi billion eye disease areas - DME and dry eye - plus rare optic neuro asset that can work in MS!
0
0
0
0
31
2000Man รีโพสต์แล้ว
Why must we all agree that we’ve reached the end of days for biomedical innovation? That’s indeed what we disagree on. It’s what people thought 20 years ago and many times since. Every time market drops, someone assumes it’s the end. Always wrong to bet against progress.
1
1
1
0
0
United States เทรนด์
- 1. Carson Beck 12.5K posts
- 2. Miami 90.2K posts
- 3. Louisville 19.2K posts
- 4. Ohtani 65.1K posts
- 5. #SmackDown 46.8K posts
- 6. #BostonBlue 5,553 posts
- 7. Jeff Brohm 1,643 posts
- 8. Malachi Toney 2,331 posts
- 9. George Santos 62.6K posts
- 10. Mario Cristobal N/A
- 11. Chris Bell 1,935 posts
- 12. #OPLive 2,110 posts
- 13. Geno 9,201 posts
- 14. Nebraska 12.7K posts
- 15. 4 INTs N/A
- 16. Ilja 19K posts
- 17. The U 565K posts
- 18. Raiola 2,196 posts
- 19. Suarez 29K posts
- 20. Minnesota 46.1K posts
คุณอาจชื่นชอบ
-
Katzung
@KatzungMD -
aIChris
@biotech_chris -
Rajesh Devraj
@r_devraj -
vale
@BitMizan -
Coz ☀️
@GMCoz -
Vidit Goyal
@_viditgoyal -
Marta Oliva
@molivasantiago -
Abhik Ghosh Moulick
@abhikgmoulick -
Yuuki Hosokawa
@yuukihosok -
Ashoka Madduri
@ashokamadduri -
👻🦇 Spooky Maris ❤️🔥
@badwitchmaris -
Shambala Vibes
@bretcolson
Loading...
Something went wrong.
Something went wrong.